Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Public Health and Preventive Medicine
  4. Vol 2, Issue 3, 2022

Mechanism and Research Progress of Danqu Capsule in the Treatment of Maintenance Hemodialysis Complicated with Cardiovascular Disease

Download as PDF

DOI: 10.23977/phpm.2022.020302 | Downloads: 13 | Views: 595

Author(s)

Xi Chen 1, Kaixuan Dong 1, Rong Zhou 1, Xiaoyong Yu 2

Affiliation(s)

1 The First Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang 712046, China
2 Department of Nephrology, Shaanxi Hospital of Traditional Chinese Medicine, Xi'an 710003, China

Corresponding Author

Xiaoyong Yu

ABSTRACT

There are many Cardiovascular risk factors in patients with maintenance hemodialysis (MHD), which is a high risk population of Cardiovascular disease (CVD) and an important cause of death in MHD patients. Danqu capsule is a traditional Chinese medicine compound preparation made by Shaanxi Hospital of Traditional Chinese Medicine. It has been found in the preliminary clinical observation that Danqu capsule can significantly improve the clinical symptoms of patients with coronary heart disease angina pectoris syndrome of phlegm-stasis interaction type, and improve the quality of life of patients. Through literature review, the pathogenesis of MHD combined with CVD in Traditional Chinese and western medicine was reviewed, and the mechanism of danqu capsule in the treatment of MHD combined with CVD was elaborated, in order to provide reference for clinical research and treatment promotion of MHD combined with CVD.

KEYWORDS

Danqu capsule, Hemodialysis, Cardiovascular disease, Mechanism of action, Research progress

CITE THIS PAPER

Xi Chen, Kaixuan Dong, Rong Zhou, Xiaoyong Yu, Mechanism and Research Progress of Danqu Capsule in the Treatment of Maintenance Hemodialysis Complicated with Cardiovascular Disease. MEDS Public Health and Preventive Medicine (2022) Vol. 2: 7-13. DOI: http://dx.doi.org/10.23977/phpm.2022.020302.

REFERENCES

[1] Cen J H. Risk factors for death in hemodialysis patients: a meta-analysis [J]. J Clinical Rational Drug Use, 201,14(20): 153-155. (In Chinese)
[2] Zhang X H, Li J Wang L H. Long-term survival of patients undergoing maintenance hemodialysis [J]. Chin J hematol, 2019,18(12):826-829.
[3] Fan H, An J, Liu C F, et al. Effect of danqu prescription on angina pectoris of coronary heart disease [J]. Shaanxi traditional Chinese medicine, 2014, 35(08): 973-975.
[4] Yang Shao-ning, SUN Qian, LI Shan-shan, ZENG Xiao-rong, XU Xin-li, YU Xiao-yong. Effect of Danqu capsule on microinflammatory status and symptom score in patients with phlegm-stasis interaction maintenance hemodialysis [J]. Journal of liaoning university of traditional Chinese medicine: 1-15 [2022-02-28]. HTTP: //http://kns.cnki.net/kcms/ detail/ 21.1543.r.20220209.1154.005.html.
[5] Song L Q, Yun J, Song Y X. Chinese journal of nephropathy, 2013,2(05):237-241. (In Chinese)
[6] He Q. Cardiovascular risk factors of chronic renal failure [J]. China sanatorio med, 2010, 19(03): 241-243.
[7] Zhao Q, Yang S F, GAO Q Q. Association of plasma arteriosclerosis index with inflammatory factors and cardiovascular disease in patients with chronic renal failure on maintenance hemodialysis [J]. Clinical misdiagnosis and mismanagement,2019,32(04): 79-83.
[8] Li D N, Zhu S Y, Luo C Z. Effect of hemodialysis on microinflammatory factors and vascular calcification in patients with chronic kidney disease and cardiovascular disease [J]. Hainan Medical Journal, 201, 32(13): 1652-1654.
[9] Li K L, LI J F, Wu L C. Study on the relationship between hyperhomocysteine and atherosclerosis in uremic hemodialysis patients [J]. Chinese journal of pharmaceutical sciences, 2020, 10(06): 248-251.
[10] Zheng P D. Etiology, pathogenesis, differentiation and treatment of chronic renal failure [J]. Journal of Shanghai University of Traditional Chinese Medicine, 2008(02): 1-3.
[11] Yu M, Wang J, Shi Y X, et al. Chronic renal failure from the theory of phlegm and blood stasis treatment [J]. China journal of traditional Chinese medicine, 2009, 27(06): 1166-1169.
[12] Wu R X, Gao W H, Zou X F, et al. "Heart-kidney Correlation" theory in Treatise on Febrile Diseases and its influence on later generations [J]. Chinese Journal of Traditional Chinese Medicine, 201, 49(07): 93-96.
[13] Wen Y J. Enlightenment of clinical thinking based on the theory of phlegm and blood stasis interaction of Traditional Chinese Medicine master Lei Zhongyi [J]. Shaanxi traditional Chinese medicine, 2020, 41(07): 948-950.
[14] Xu Y, Chen T, Chen M Advances in studies on chemical constituents and pharmacological effects of Salvia miltiorrhiza [J]. Haixia Pharmacy, 201,33(05):45-48.
[15] Sun N Y, Zhu X L, Chen J. Research progress on anti-fibrosis pharmacological action and mechanism of chemical constituents of salvia miltiorrhiza [J]. Chinese journal of experimental traditional Chinese medicine, 2020, 26(22): 201-208.
[16] Lu X H, Ma X, Wang J, et al. Research progress on chemical constituents and pharmacological action of paeonia lactiflora [J]. Chinese traditional and herbal medicines, 2015,46(04):595-602.
[17] Ren L, Cao H Z, Ji W Y. Study on the mechanism of radix Paeoniae paeoniae in the treatment of atherosclerosis based on network pharmacology [J]. Henan Traditional Chinese Medicine, 201, 41(04): 622-627.
[18] He M, Feng X L,Yue P Y, et al. Effect of paeonol on renal fibrosis after unilateral ureteral obstruction in mice [J]. Chin J toxicol, 2020, 34(01): 25-30.
[19] Wang Y, Liu J Y, Liu S Q. Research progress on the mechanism of leeches in the treatment of cardiovascular and cerebrovascular diseases [J]. Chin J Med, 201,18(07):47-50.
[20] Li N, Wang F Y, Gao X L, et al. Research progress of sanqi in prevention and treatment of renal fibrosis [J]. Chinese patent medicine, 2020,42(11):2974-2978.
[21] Li Z. Study on anti-inflammatory and antioxidant effects of Danlou tablet in rats with coronary heart disease syndrome of phlegm-stasis interaction based on serum metabonomics [D]. Tianjin University of Traditional Chinese Medicine, 2020.
[22] Ding Y, Zhang B, Zhou K, et al. Dietary ellagic acid improves oxidant-induced endothelial dysfunction and atherosclerosis: role of Nrf2 activation [J]. Int J Cardiol, 2014,175(3): 508-514.
[23] Liu X R, Li J. Chinese journal of gerontology, 2015,35(17): 4800-4801.]
[24] Chen Z K, Hu S J, Sun J, Xia Q, Shen Y L, et al. Acute effects of Astragalus membranaceus on blood pressure in spontaneously hypertensive rats [J]. Chinese Journal of Experimental Diagnosis, 2003(05): 403-405.
[25] Zhou X Z,Lin S F, He S H. Advances in pharmaceutical evaluation of monascus [J]. China modern Chinese materia medica, 2016,18(07):936-941.
[26] Tang J J,Wang S H, Li G X, et al. Treatment of ciH-induced dyslipidemia and arteriosclerosis with Danlou Tablets and the regulatory mechanism of HIF-1α -AngPTL4 mRNA [Z]. 2018.
[27] Zhang Z Q, Zhao L, Ma X. Protective effect of danlou tablet on fatty liver disease complicated with hyperlipidemia in rats [J]. Chinese journal of traditional Chinese medicine, 2017,32(08):1470-1474.
[28] Huang Y, Wang Q, Zhu X W, et al. Effect of trichosanthes trichosanthes on coronary heart disease [J]. Chin J cardiol, 2019, 7(23): 18.
[29] Luo X, Liang X W. Efficacy and safety of ginkgo biloba extract in treatment of essential hypertension with hyperlipidemia [J]. Journal of hebei north university (natural science edition), 2015, 31(05): 64-68.
[30] Zhang Q, Wang G J, A J Y, et al. Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats[J]. Acta Pharmacol Sin, 2009,30(12):1674-1687.
[31] Chen Y, Wen J Y, Xie X F, et al. Research progress on chemical constituents and pharmacological action of Pueraria [J]. Chinese Materia Medica & Clinic, 201,12(01):53-60.
[32] Zhu M J. Effects of puerarin on oxidative stress injury and its mechanism in renal ischemia-reperfusion rats [J]. Journal of modern integrated Chinese and western medicine, 2016,25(06):585-589.
[33] Wang Y M,Wang Q H.Research progress on chemical constituents, pharmacological action and toxicity of pinellia ternata [J]. China pharmacy, 2020,31(21):2676-2682. (In Chinese).
[34] Huang F Y, Gao J L, Gong Q H. Research progress on pharmacological effects and toxicity of pinellia ternata [J]. Natural products research and development, 2020,32(10): 1773-1781. (In Chinese).
[35] Fu L, Fu Q, Li J, et al. Research progress on chemical Constituents and pharmacological action of Coptis chinensis [J]. Journal of Traditional Chinese Medicine, 201,49(02):87-92.
[36] Huang L. Research progress of chemical constituents and pharmacological activities of active components of coptis chinensis [J]. Journal of cardiovascular diseases of integrated traditional and western medicine, 2020, 8(17): 136-137.
[37] Sheng Y H, Li M M, Guo Y L, et al. Research progress on chemical constituents of allium macrostemon and their extraction and isolation [J]. Specialty research, 2020, 42(05): 61-70.
[38] Sun Y, Liu Y R, Wu H F, et al. Effect and mechanism of paeonol on atherosclerotic cells [J]. Journal of anhui university of traditional Chinese medicine, 2020, 39(03): 92-96.
[39] Tian X, XU P, Liu C F. Mitochondrial protective mechanism of danqu capsule against myocardial ischemia-reperfusion injury [J]. Chin J pharmacol, 2018, 15(36): 16-19.
[40] Chen J F, Jing L, Gao C, et al. Effects of Danqu Capsule on arterial blood pressure, Heart rate and myocardial tension time index in anesthetized rats [J]. Journal of practical cardio-cerebral pulmonary vascular diseases, 2020, 28(12): 85-91.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 1812
Visits: 84700

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.